[Therapy of malignant melanoma with beta-interferons].
Since June, 1985, we have been treating 18 evaluable patients suffering from high risk melanoma with human beta-interferon (HBIF), 10 of the patients received HBIF infusions, 8 patients got subcutaneous injections into the regional lymph nodes. In some of the cases, this treatment resulted in obviously prolonged survival times; at present, however, the effect of HBIF is still beyond calculation.